FDA Orange Book

Is there a generic for Fruzaqla?

Fruzaqla contains fruquintinib. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Fruzaqla (fruquintinib). The Orange Book shows its last listed patent expires September 7, 2035 and its last listed exclusivity ends November 8, 2028.

Run it in Rivvi

Map Fruzaqla and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Fruzaqla products in the Orange Book

Fruzaqla products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
capsule, oral1MGMarketed (Rx)None0None
capsule, oral5MGMarketed (Rx)None0None

NDA 217564, held by TAKEDA PHARMACEUTICALS USA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Fruzaqla patents

Patents listed for Fruzaqla
PatentExpiresCoversUse codeNDA
8212033May 9, 2028Method of useU-3753217564
7829574March 23, 2032Drug substance, Drug productNone217564
11046674September 7, 2035Method of useU-3753217564
10519142September 7, 2035Drug substance, Drug productU-3753217564

Fruzaqla exclusivity

Exclusivity listed for Fruzaqla
CodeMeaningExpiresNDA
NCENew chemical entityNovember 8, 2028217564

Fruzaqla NDC codes

Questions

Is there a generic for Fruzaqla?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Fruzaqla (fruquintinib). The Orange Book shows its last listed patent expires September 7, 2035 and its last listed exclusivity ends November 8, 2028.

What is the generic name for Fruzaqla?

The active ingredient in Fruzaqla is fruquintinib, per the FDA Orange Book.

When does the Fruzaqla patent expire?

The last patent listed for Fruzaqla in the Orange Book expires September 7, 2035. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Fruzaqla and Fruquintinib

Try it on your own data today.

Free to start. Most teams are using it the same day.